The IMPACT Implementation-Effectiveness Trial
- Disease/Condition
- Cancer
- Drug/Device/Intervention
- Exercise
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- McMaster University
- Phase
- Phase 2
- Start date
- Mar 15, 2024
- End date
- Mar 15, 2027
- Enrollment
- 129 participants
Physical activity level
More Canadians are surviving cancer, however, individuals with cancer live with side effects
 for years after treatments have ended. The physical and psychosocial benefits of regular
 physical activity (PA) during and after cancer treatment are well established. However, less
 than 30% of individuals with cancer meet current PA recommendations and PA levels decline
 significantly during treatment. PA services within the cancer institution to support
 well-being during treatment are not available for survivors across Ontario. Strategies are
 needed within cancer centres to close the gap between the evidence and clinical practice.
 
 What is the purpose? To evaluate the effectiveness of a novel exercise and education strategy
 for individuals with cancer during treatment.
 
 What are we proposing to do? This project includes two parts. In Part 1 participants will be
 put into one of three groups. Group 1 (Exercise & self-management) will include eight
 sessions of supervised, institution-based exercise and self-management education. Group 2
 (self-management only) will include eight virtual self-management education sessions with an
 exercise professional. Group 3 will receive usual care (i.e., no intervention).
 
 In Part 2 participants who attended less than 75% of their sessions will be asked to complete
 an interview on the barriers to continuing with the study during cancer treatment.
 
 Why is this work important? Findings from this trial will inform the way PA services are
 provided within cancer institutions across Ontario. This novel strategy incorporates both
 institution-based and home-based exercise strategies during treatment and highlights the
 importance of individuals with cancer taking an active role in managing their condition
 during treatment. This can prevent future complications and decrease burden on the individual
 and the healthcare system. Results will inform future decisions on PA implementation
 strategies for cancer survivors with diverse needs across Ontario.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06323707
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06323707 through Pure Global AI's free database. This Phase 2 trial is sponsored by McMaster University and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 129 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.